Enable JavaScript to visit this website.
Skip directly to content



Consumers with questions regarding this recall can contact Pfizer Medical Information at 1-800-463-6001 between 9:00 a.m. and 5:00 p.m. EST.


Adverse reactions or quality problems experienced with the use of this product may be reported to 1-866-723-7111 or by fax at 1-855-242-5652. Reports can be made directly to Health Canada as well through the Canada Vigilance Program at 1-866-234-2345.


For media queries, please contact:

Pfizer Canada Corporate Affairs
1-866-9Pfizer (1 866 973-4937)
[email protected]

Important Safety Information

EpiPen® (epinephrine) Auto‐Injectors are indicated for the emergency treatment of anaphylactic reactions in patients who are determined by a physician to be at increased risk for anaphylaxis. EpiPen® (epinephrine) Auto‐Injectors are designed as emergency supportive therapy only. After administration, patients should seek medical attention immediately or go to the nearest emergency room. This product may not be right for you, always read and follow the label.

EpiPen® and EpiPen® Jr are a registered trademark of Mylan, Inc. licensed exclusively to its wholly-owned affiliate, Mylan Specialty, L.P.; sub-licensee, Pfizer Canada, Kirkland, Quebec H9J 2M5